Reparixin improves survival in critically ill and transplant patients: A meta-analysis.

Gioia Piersanti,Giovanni Landoni,Tommaso Scquizzato,Alberto Zangrillo,Lorenzo Piemonti

European journal of clinical investigation（2023）

引用 0|浏览3

暂无评分

摘要

The findings of this meta-analysis indicate that reparixin, an anti-inflammatory drug, improved survival in critically ill or transplant patients (including both COVID-19 and non-COVID-19 patients) without increasing the risk of infection.

查看译文

关键词

transplant patients

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要